Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or bendamustine or Bcl-2 inhibitor combined with CHOP

Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or bendamustine or Bcl-2 inhibitor combined with CHOP

US Patent 11554127 · Granted Jan 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clothes drying device and heat supply method therefor2025
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors2025
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors2025
Storage shed2025
Storage box2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Combination of immunotherapies with MDM2 inhibitors2025
Combination of immunotherapies with MDM2 inhibitors2025
Storage shed2025